Jacqueline C. Barrientos, MD | Authors

Articles

Selecting Patients for Treatment With Ibrutinib in CLL

April 14, 2018

Jacqueline C. Barrientos, MD, associate professor of the Karches Center for Oncology Research at the Feinstein Institute for Medical Research, discusses which types of patients with chronic lymphocytic leukemia are the best candidates for treatment with ibrutinib

Venetoclax for the Treatment of Elderly Patients With CLL

December 07, 2017

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses venetoclax (Venclexta) for the treatment of elderly patients with chronic lymphocytic leukemia (CLL).